Xilio Therapeutics, Inc.

XLO · Nasdaq · SIC 2834: Pharmaceutical Preparations
101
SEC Filings

Business Summary

5 Item 1A. Risk Factors 36 Item 1B. Unresolved Staff Comments 95 Item 1C. Cybersecurity 95 Item 2. Properties 96 Item 3. Legal Proceedings 96 Item 4. Mine Safety Disclosures 96 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 97 Item 6. [Reserved] 97 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 98 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 112 Item 8...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionXLOdiscussed_in_filing Cybersecurity
topic_mentionXLOdiscussed_in_filing Cybersecurity
topic_mentionXLOdiscussed_in_filing Cybersecurity
topic_mentionXLOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001193125-26-118550EDGAR120K words
2025-03-112024-12-310001558370-25-002640EDGAR—
2024-04-012023-12-310001558370-24-004530EDGAR—
2023-03-022022-12-310001558370-23-002687EDGAR—
2022-03-012021-12-310001558370-22-002552EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-278837EDGAR81K words
2025-08-142025-06-300001558370-25-011477EDGAR—
2025-05-082025-03-310001558370-25-006996EDGAR—
2024-11-072024-09-300001558370-24-014775EDGAR—
2024-08-082024-06-300001558370-24-011471EDGAR—
2024-05-142024-03-310001558370-24-008068EDGAR—
2023-11-092023-09-300001558370-23-018587EDGAR—
2023-08-142023-06-300001558370-23-014711EDGAR—
2023-05-092023-03-310001558370-23-008676EDGAR—
2022-11-092022-09-300001558370-22-017018EDGAR—
2022-08-092022-06-300001558370-22-012756EDGAR—
2022-05-122022-03-310001558370-22-008441EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001193125-26-118544EDGAR3K words
2026-03-120001193125-26-103150EDGAR—
2026-03-090001193125-26-097603EDGAR—
2026-02-240001193125-26-065234EDGAR—
2026-02-120001193125-26-048942EDGAR—
2026-01-080001193125-26-007063EDGAR—
2026-01-050001193125-26-001580EDGAR—
2025-11-250001193125-25-297165EDGAR—
2025-11-130001193125-25-278835EDGAR—
2025-11-070001193125-25-271189EDGAR—

101 total filings indexed. 74 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001840233
TickerXLO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8d10adb99d56d12c2e3b7ecb7fefa1801d2b1dcf9a9d5f6b79842716dcd967b8
parent: 3f151fb89214d0dfb02f8e7831d97198306e96493b062b82578186b1210a6d90
content hash: 0aca80451245b4100a744f9efeea1f04c026392853233eda2452b7bcc8ae5a07
signed: 2026-04-13T04:48:18.198Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf